Filter
1917
Filtered Results: 1917
Text search:
and
A.
Rouse
Featured
Recommendations
272
New Publications
411
Language
Document type
No document type
587
Guidelines
443
Studies & Reports
418
Manuals
224
Strategic & Response Plan
115
Training Material
69
Fact sheets
37
Infographics
8
Situation Updates
7
Resource Platforms
5
Brochures
3
Videos
1
Countries / Regions
Global
142
India
68
Latin America and the Carribbean
36
Western and Central Europe
33
Liberia
32
Kenya
32
South–East Asia Region
28
Sierra Leone
27
Nigeria
26
Ukraine
26
Africa
25
Eastern Europe and Central Asia
21
Ethiopia
20
Rwanda
20
South Africa
19
Uganda
17
Ghana
16
Myanmar / Burma
16
Philippines
15
Tanzania
14
Bangladesh
14
Syria
13
Nepal
12
Middle East and North Africa
12
South Sudan
11
West and Central Africa
11
Asia
11
Guinea
10
Congo, Democratic Republic of
10
East and Southern Africa
10
Western Pacific Region
9
Haiti
7
Malawi
7
Yemen
7
Pakistan
6
Afghanistan
6
Russia
6
Somalia
5
Jordan
5
Zambia
5
Sudan
5
Senegal
4
Iraq
4
Lebanon
4
Cambodia
4
Thailand
4
Eastern Europe
4
Tajikistan
4
Burkina Faso
3
Côte d’Ivoire / Ivory Coast
3
Cameroon
3
Egypt
3
Mozambique
3
Namibia
3
North Macedonia
3
Venezuela
3
Timor Leste/ East Timor
3
Iran
3
Mali
2
USA
2
Saudi Arabia
2
Zimbabwe
2
Turkey
2
Indonesia
2
Peru
2
Eswatini/ Swaziland
2
Colombia
2
Ecuador
2
Botswana
2
Lesotho
2
Djibouti
2
Laos
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Vietnam
2
North America
2
Morocco
1
Germany
1
Chad
1
China
1
Ireland
1
Singapore
1
Benin
1
Brazil
1
Serbia
1
Bolivia
1
Greece
1
Libya
1
Angola
1
Sri Lanka
1
Chile
1
Paraguay
1
Bhutan
1
Palestine
1
North Korea
1
Albania
1
Armenia
1
Mongolia
1
Qatar
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
421
Clinical Guidelines
261
Public Health
185
Key Resources
167
Women & Child Health
150
Capacity Building
62
Pharmacy & Technologies
57
Toolboxes
COVID-19
212
HIV
131
Mental Health
130
Caregiver
118
Planetary Health
118
TB
108
Rapid Response
88
AMR
86
Ebola
79
NTDs
68
Pharmacy
55
Global Health Education
53
NCDs
48
Disability
40
Conflict
40
Natural Hazards
31
Refugee
23
Health Financing Toolbox
15
Cholera
11
Specific Hazards
9
Polio
7
Zika
5
Social Ethics
2
Europe and Central Asia Economic Update.
The Russian Federation’s war with Ukraine has triggered a catastrophic humanitarian crisis and threaten...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococ...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to m...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagn...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropr...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and...
The Water and Sanitation for Health Facility Improvement Tool (WASH FIT) presents a framework and acts as ... guide to support multisectoral action to improve water, sanitation and hygiene (WASH) in health care. Central to the WASH FIT methodology is training and incremental improvements.
Implementation of WASH FIT requires six preparatory steps at the national level, one of which is conducting national sensitization and training of trainers, followed by facility-level training. At the facility level, step 1 (of five) involves establishing and training a WASH FIT team.
The WASH FIT methodology is outlined in WASH FIT: A practical guide for improving quality of care through water, sanitation and hygiene in health care facilities. Second edition. (the WASH FIT guide), which includes a set of templates designed to help users with each phase of the improvement cycle.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagn...
A manual to train health-care workers on practising, teaching and observing hand hygiene.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines i...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD ri...
HEARTS provides a set of locally adaptable tools for strengthening the
management of CVD in primary health care.
HEARTS is designed to enhance implementation of WHO PEN by providing:
• operational guidance on further integrating CVD management
...
Hesperian released a Coronavirus (COVID-19) Fact Sheet specifically for people like you, individuals and organizations seeking credible resources. Thanks to the incredible skill ... participation of many partners on short notice, it is available now in English, Spanish, French, Chinese, Urdu, Bangla, Filipino, Vietnamese, Bahasa Indonesia, Farsi, Sindhi, Telugu, and Hindi on the website. Fact sheets in Shona, Portuguese, Arabic, and Chichewa are on the way.
The purpose of the review was to assign a cause of death, to ascertain the fac-tors that contributed to the death and to identify any systemic issues that could be addressed to prevent future simila...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has ... much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should have some familiarity with palliative care, so that general palliative care principles are available to all patients. The timely identification, and addressing, of adverse events occurring during the treatment course is considered as general palliative care for those receiving curative treatment. This publication summarizes the general palliative care approach, which is recommended for use in settings and services that occasionally treat palliative care patients, but do not provide palliative care as the main focus of their work. The review focuses on 18 high TB priority countries of the WHO European Region.
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbat...
For 50 SAM children with medical complications and for a paediatric ward of 10-15 beds for 3 months
The PED/SAM kit is especially designed to provide medicines, renewables ... equipment suitable for children and to treat the common childhood illness including severe acute malnutrition with medical complications.
This kit does NOT contain any food supplements, TB, HIV medicines or vaccines.
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) a... hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele and over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
